1. Home
  2. CDNA vs ATRC Comparison

CDNA vs ATRC Comparison

Compare CDNA & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • ATRC
  • Stock Information
  • Founded
  • CDNA 1998
  • ATRC 2000
  • Country
  • CDNA United States
  • ATRC United States
  • Employees
  • CDNA N/A
  • ATRC N/A
  • Industry
  • CDNA Medical Specialities
  • ATRC Medical/Dental Instruments
  • Sector
  • CDNA Health Care
  • ATRC Health Care
  • Exchange
  • CDNA Nasdaq
  • ATRC Nasdaq
  • Market Cap
  • CDNA 712.2M
  • ATRC 1.7B
  • IPO Year
  • CDNA 2014
  • ATRC 2005
  • Fundamental
  • Price
  • CDNA $13.73
  • ATRC $35.05
  • Analyst Decision
  • CDNA Buy
  • ATRC Strong Buy
  • Analyst Count
  • CDNA 8
  • ATRC 10
  • Target Price
  • CDNA $26.86
  • ATRC $49.60
  • AVG Volume (30 Days)
  • CDNA 1.5M
  • ATRC 411.6K
  • Earning Date
  • CDNA 11-03-2025
  • ATRC 10-28-2025
  • Dividend Yield
  • CDNA N/A
  • ATRC N/A
  • EPS Growth
  • CDNA N/A
  • ATRC N/A
  • EPS
  • CDNA 1.00
  • ATRC N/A
  • Revenue
  • CDNA $340,826,000.00
  • ATRC $499,946,000.00
  • Revenue This Year
  • CDNA $13.02
  • ATRC $16.32
  • Revenue Next Year
  • CDNA $12.85
  • ATRC $12.37
  • P/E Ratio
  • CDNA $13.56
  • ATRC N/A
  • Revenue Growth
  • CDNA 14.72
  • ATRC 16.28
  • 52 Week Low
  • CDNA $10.96
  • ATRC $25.57
  • 52 Week High
  • CDNA $32.97
  • ATRC $43.11
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 53.37
  • ATRC 48.59
  • Support Level
  • CDNA $13.23
  • ATRC $34.57
  • Resistance Level
  • CDNA $13.80
  • ATRC $38.08
  • Average True Range (ATR)
  • CDNA 0.66
  • ATRC 1.38
  • MACD
  • CDNA 0.15
  • ATRC -0.24
  • Stochastic Oscillator
  • CDNA 68.85
  • ATRC 25.00

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Share on Social Networks: